Suppr超能文献

从大鼠肝脏和肝癌中纯化并鉴定一种能够激活多聚腺苷酸聚合酶的核蛋白激酶。

Purification and characterization of a nuclear protein kinase from rat liver and a hepatoma that is capable of activating poly(A) polymerase.

作者信息

Stetler D A, Seidel B L, Jacob S T

出版信息

J Biol Chem. 1984 Dec 10;259(23):14481-5.

PMID:6094560
Abstract

The cyclic nucleotide-independent protein kinase which is separated from poly(A) polymerase during its purification from nuclei of rat liver and Morris hepatoma 3924A was purified essentially to homogeneity. Liver nuclear poly(A) polymerase was dissociated from protein kinase by phosphocellulose column chromatography. In contrast, protein kinase copurified with the hepatoma poly(A) polymerase on the phosphocellulose column. Neither liver nor hepatoma kinase was stimulated by spermine or inhibited by heparin. These enzymes did not utilize GTP as phosphoryl donor, or histones or tyrosine-containing [Val5]-angiotensin II as phosphoryl acceptors. The apparent Km with respect to ATP was similar for the liver (4.7 microM) and hepatoma (11 microM) kinases, and the apparent Km with respect to casein was identical (0.6 microgram/microliter) for these enzymes. Both enzymes were capable of phosphorylating poly(A) polymerase and stimulating both tumor and liver poly(A) polymerase activity. However, in addition to their different chromatographic properties, the two kinases differed in molecular weight (liver, 37,000; hepatoma, 56,000), in their response to various divalent metal ions, and in their ability to phosphorylate hepatoma poly(A) polymerase (Km 7.9 and 30 microgram/microliter for liver and hepatoma enzymes, respectively). These latter characteristics distinguished the liver and hepatoma protein kinases from each other as well as from the previously described NI protein kinase.

摘要

在从大鼠肝脏和莫里斯肝癌3924A细胞核中纯化聚腺苷酸聚合酶的过程中分离出的不依赖环核苷酸的蛋白激酶,基本上被纯化至同质。肝细胞核聚腺苷酸聚合酶通过磷酸纤维素柱色谱与蛋白激酶解离。相比之下,蛋白激酶在磷酸纤维素柱上与肝癌聚腺苷酸聚合酶共纯化。肝脏和肝癌激酶均不受精胺刺激,也不受肝素抑制。这些酶不利用GTP作为磷酰基供体,也不利用组蛋白或含酪氨酸的[缬氨酸5] - 血管紧张素II作为磷酰基受体。肝脏激酶(4.7 microM)和肝癌激酶(11 microM)对ATP的表观Km相似,并且这些酶对酪蛋白的表观Km相同(0.6微克/微升)。两种酶都能够磷酸化聚腺苷酸聚合酶并刺激肿瘤和肝脏聚腺苷酸聚合酶的活性。然而,除了它们不同的色谱特性外,这两种激酶在分子量(肝脏,37,000;肝癌,56,000)、对各种二价金属离子的反应以及磷酸化肝癌聚腺苷酸聚合酶的能力(肝脏和肝癌酶的Km分别为7.9和30微克/微升)方面也有所不同。这些后者的特性将肝脏和肝癌蛋白激酶彼此区分开来,也与先前描述的NI蛋白激酶区分开来。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验